Safety Profiles
Evidence-based safety information for peptides, including side effects, interactions, and regulatory status.
Important Notice
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.
Showing 31 safety profiles
AOD-9604 Safety Information
Safety information for AOD-9604, which failed clinical trials but is still sold illegally.
BPC-157 Safety Profile
BPC-157 is not FDA-approved. Most evidence comes from animal studies and a single research group. Human safety data is extremely limited.
CJC-1295 Safety Profile
CJC-1295 is not FDA-approved. Clinical trials were discontinued. Two variants exist (with and without DAC), creating confusion and safety concerns.
Dihexa Safety Profile
Safety assessment of dihexa based on preclinical research. NO human safety data exists.
DSIP Safety Profile
Safety overview of Delta Sleep-Inducing Peptide (DSIP), a CNS-active peptide with limited and inconsistent clinical data.
Epithalon Safety Concerns
Critical evaluation of epithalon safety claims and evidence quality.
FOXO4-DRI Safety Profile
Safety assessment of FOXO4-DRI senolytic peptide. Only studied in aged mice—zero human data.
General Safety: Unregulated Peptides
Important safety information about using peptides from unregulated sources.
GHK-Cu Safety Profile
Naturally occurring peptide-copper complex. Generally regarded as safe in cosmetic topical use. Injectable safety NOT established. Copper toxicity concerns at high doses.
GLP-1 Agonist Safety Overview
Clinical trial safety data and post-marketing surveillance findings for GLP-1 receptor agonists including tirzepatide and semaglutide. Covers common side effects, serious adverse events, boxed warnings, and contraindications.
Growth Hormone Peptide Safety
Safety considerations for unapproved growth hormone-releasing peptides.
Humanin Safety Profile
Safety overview of Humanin, a mitochondrial-derived peptide with no human clinical data for exogenous administration.
Ipamorelin Safety Profile
Ipamorelin is not FDA-approved. Development was discontinued despite early clinical trials. Limited human safety data exists from incomplete studies.
KPV Safety Profile
Safety overview of KPV tripeptide (Lys-Pro-Val), an anti-inflammatory peptide with minimal human safety data.
Liraglutide Safety Profile
FDA-approved GLP-1 agonist with extensive clinical safety data. Common GI side effects. Boxed warning for thyroid C-cell tumors (rodent studies).
LL-37 Safety Profile
Safety assessment of LL-37 antimicrobial peptide. Endogenous compound with limited exogenous administration data.
Melanotan II Safety Warning
Critical safety warnings about Melanotan II from regulatory agencies worldwide.
MK-677 Safety Profile
MK-677 is not FDA-approved. More human data exists compared to most research peptides, but development was discontinued. Known effects on glucose metabolism raise safety concerns.
MOTS-c Safety Profile
Safety overview of MOTS-c, a mitochondrial-derived peptide with limited human data and no FDA approval.
PT-141 (Vyleesi) Safety Profile
Safety information for FDA-approved PT-141 (bremelanotide/Vyleesi) for HSDD.
Recovery Peptide Safety (BPC-157, TB-500)
Safety considerations for unapproved recovery peptides BPC-157 and TB-500.
Retatrutide Safety Profile
Safety profile of retatrutide based on Phase 2 clinical trial data. Triple incretin agonist in active development by Eli Lilly.
Selank Safety Profile
Approved in Russia for anxiety, NOT approved by FDA/EMA. Limited Western safety data. Russian literature suggests mild side effect profile.
Semaglutide Safety Profile
Safety information for semaglutide including common side effects, warnings, and contraindications.
Semax Safety Profile
Approved in Russia for stroke and cognitive conditions. NOT approved by FDA/EMA. Russian data suggests mild profile. Limited Western validation.
Sermorelin Safety Profile
Former FDA-approved GHRH analog (Geref, discontinued). Clinical safety data exists. Now available as compounded product. Better safety profile than exogenous GH.
SS-31 (Elamipretide) Safety Profile
Safety overview of SS-31 (elamipretide), the most clinically advanced mitochondrial peptide with Phase 3 trial data.
TB-500 Safety Profile
TB-500 is not FDA-approved and has not been tested in human clinical trials. It is a synthetic fragment of thymosin beta-4 with no established human safety profile.
Tesamorelin Safety Profile
Safety information for FDA-approved tesamorelin (Egrifta) for HIV lipodystrophy.
Thymosin Alpha-1 Safety Profile
Safety profile of thymosin alpha-1 based on clinical trial data and international regulatory approvals.
Tirzepatide Safety Profile
Safety information for tirzepatide including common side effects, warnings, and contraindications.